Enliven Insider Buying Signals Bullish Outlook After Strong Trial Results
Insider buying fuels optimism for Enliven Therapeutics after Phase 1b success; investors eye potential upside amid high‑growth biotech volatility.
3 minutes to read
ENLIVEN THERAPEUTICS INC